René Medema

René Medema

We have been using the complete DNA test for the past two years in the routine care of patients with cancer. The test provides at least as much, and often more, information we can use to treat our patients than regular tests. Moreover, in patients with an unknown primary tumor, it can help us to diagnose the cancer and find a treatment. This test also makes a difference for patients with a sarcoma. Our researchers have scientifically demonstrated this in several studies.

Back to news

More news

Whole Genome Sequencing for cancer diagnostics clinically validated

Whole Genome Sequencing for cancer diagnostics clinically validated

18-05-2021

Scientific research has demonstrated that Whole Genome Sequencing (WGS) is at least as reliable as routine diagnostic procedures. Clinical Molecular …

Whole Genome Sequencing feasible in clinical practice

Whole Genome Sequencing feasible in clinical practice

20-09-2020

Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a …

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

11-08-2022

Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl